Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;

> Pennsylvania has offered Endo Pharmaceuticals ($ENDP) $1.2 million in incentives to remain in The Keystone State in exchange for a promise of 154 jobs in three years. Story

> Wellspring Pharmaceutical, a Canadian manufacturer of specialty and OTC drugs, has been acquired by Sentinel Capital Partners and Ancor Capital Partners. Release

> Hebei Aoxing Pharmaceutical Group, unit of China's Aoxing Pharmaceuticals ($AXN), has received government funding of $315,000 for manufacturing plant improvements. News

> Lonza has announced a development and manufacturing agreement with Genmab to produce HuMax-TF, a tumor-fighting antibody-drug conjugate. Release

> Kenya's Universal Corp. has been prequalified by the World Health Organization to manufacture the HIV drug, Lamozido. Item

> A news organization's investigation has uncovered drug counterfeiting operations in parts of Delhi and adjoining western parts of Uttar Pradesh. Story

> Organization and funding troubles plague U.S. efforts to develop and produce bioterror vaccines. Story

> Adeona Pharmaceuticals ($AEN) will provide commercial-scale manufacturing for Chicago-based F&F Foods of wellZin, an oral zinc lozenge to ease symptoms of the common cold. Release

> The FDA will provide $2 million in support of two regulatory science and innovation centers at the University of Maryland and Georgetown University. Story

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.